Don’t miss to participate in the start-up competition @AMR conference supported by INCATE. Early-stage ventures fighting drug resistant bacterial infections in the therapeutics or diagnostics…
In December, a consortium of 8 public and 4 private Swiss institutions has joined forces to address the silent pandemic of AMR by launching…
Pharma company Roche is among the partners of AMR-focused incubator INCATE. We spoke with Rusudan Okujava about the motivation of Roche to support the…
In late December, FIND announced an investment of US$21 million to accelerate the development, manufacturing, and launch of affordable, multi-pathogen, molecular diagnostic platforms, specifically…
On the occasion of the World Antibiotic Awareness Week (WAAW), BEAM Alliance has published a series of comics illustrating behind the scenes impressions of…
BEAM Alliance is among the partners of AMR-focused incubator INCATE. We spoke with Marc Gitzinger, CEO of BioVersys and Vice-President of the BEAM Alliance…
Together with the International Development Research Center (IDRC), the Global AMR R&D Hub published a new report analysing the funding patterns of animal health…
The Boehringer Ingelheim Venture Fund is among the industry partners of AMR-focused incubator INCATE. We spoke with investment manager Philipp Müller who is part…
The Japanese pharma company Shionogi is among the industry partners of AMR-focused incubator INCATE. We spoke with infectious disease expert Hideki Maki who represents…
